Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostair crossover study in idiopathic pulmonary fibrosis
2013-004404-19Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of beclometasone dipropionate + formoterol in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Biomarkers for platelet adhesion and activation. Started Mar 2014; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2013-004404-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004404-19.